🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

"Clinical Ultrasound, a New Link Between Town and Hospital in Seine-Saint-Denis". (ECHO93)

RecruitingNAAges 18 Years - anyAllAssistance Publique - Hôpitaux de Paris
NCT06774924 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The ECHO93 study is a non-healthcare interventional study. Its aim is to evaluate the effect of introducing the echOpen probe into the management of patients referred to the Jean Verdier UDR, in terms of time to diagnosis. The study is divided into 3 phases: Phase 1: opening of the Rapid Diagnosis Unit (UDR) at Jean Verdier Hospital Phase 2: Opening of the Jean Verdier Hospital UDR, MSP Pantin, Dr TAYBALY's medical practice in Aulnay-sous-Bois, one month after the start of phase 1. Phase 3: Opening of the Jean Verdier Hospital Health Bus, one month after the start of phase 2.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adult patient over 18 years of age 2. Patient with signed informed consent 3. Patient managed by: * one of the structures involved (UDR/ SAU Jean Verdier, MSP Pantin, Cabinet Médical du Dr TAYBALY à Aulnay-sous-Bois) for referral to the UDR for rapid diagnosis (phases 1 and 2) * the Health Bus (phase 3) Exclusion Criteria: 1. Patient on the UDR iron-deficiency anemia clinical pathway 2. Patient deprived of liberty by judicial or administrative decision 3. Patient who does not speak French and cannot benefit from the presence of a relative or translator (physical or online) 4. Patient with a contraindication to the use of EchOPen: * patients with a body mass index greater than 34.9 kg/m2 * life-threatening patients requiring emergency medical care.
💊

What it tests

  • Echoscopy examination using the echOpen probe
📍

Where

1 site
Unite de Diagnostic Rapide - Medecine Interne Hopital Jean Verdier
Bondy, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy